Renaissance Capital logo

ZGNX News

US IPO market slows pace in shortened holiday week with four tepid debuts

The US IPO market slowed this week with four small companies raising less than $100 million in their deals and seeing lukewarm receptions from IPO investors. Biotechs Zogenix (ZGNX) and...read more

Chinese real estate agency services provider SYSWIN prices IPO at $7 per ADS; raises $67 million

SYSWIN, a leading provider of real estate agency services to property developers in Beijing, raised $67 million by selling 9.6 million ADSs at $7, well below its originally anticipated terms of 12 million ADSs at a price of $9.25 to $11.25. Earlier on Tuesday,...read more

Zogenix prices IPO at $4, raises $56 million to fund drug development

Zogenix, which recently launched Sumavel DosePro, a needle-free injectable migraine treatment, raised $56 million by offering 14 million shares (versus 6 million shares as originally planned) at $4, a sharp 69% discount to its proposed range of $12 to $14. ...read more

4 IPOs planned for the week of Nov 22

The following IPOs are expected to price this week:

Anacor Pharmaceuticals (ANAC), which is developing treatments for nail fungus and psoriasis using boron-based chemistry,...read more